日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV?

是否需要更换抗逆转录病毒药物:是否有任何抗逆转录病毒策略可以减轻 HIV 感染者的体重增加?

Debroy, Paula; Lake, Jordan E

Female Sex is Protective Against MASLD With Clinically Significant Fibrosis in a Large Cross-sectional Cohort of Persons With HIV

在一项针对大量 HIV 感染者的横断面队列研究中,女性性别对伴有临床显著纤维化的 MASLD 具有保护作用。

Wegermann, Kara; Suzuki, Ayako; Sarmiento, Elisa; Boyd, LaKeisha; Li, Yang; Wilson, Laura A; Lloyd, Audrey; Debroy, Paula; Price, Jennifer C; Woreta, Tinsay; Crandall, Holly; Sterling, Richard K; Loomba, Rohit; Chalasani, Naga; Lake, Jordan E

Circulating fibroblast growth factor 21 and growth differentiation factor 15 are associated with severity of hepatic steatosis in people with HIV.

循环中的成纤维细胞生长因子 21 和生长分化因子 15 与 HIV 感染者的肝脂肪变性严重程度相关

Debroy Paula, Pike F, Gawrieh S, Corey K E, Hartig S, Balasubramanyam A, Ailstock K, Funderburg N, Lake J E

Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men

睾酮水平受到抑制的跨性别女性比匹配的顺性别男性患冠心病的负担更低。

Lake, Jordan E; Feng, Han; Hyatt, Ana N; Miao, Hongyu; Debroy, Paula; Funderburg, Nicholas; Ailstock, Kate; Dobs, Adrian; Haberlen, Sabina; Magnani, Jared W; Margolick, Joseph B; McGowan, Kate; Palella, Frank J; Witt, Mallory D; Bhasin, Shalender; Budoff, Matthew J; Post, Wendy S; Brown, Todd T

Relationships Between Hepatic Steatosis and Frailty Differ by HIV Serostatus

肝脂肪变性与虚弱之间的关系因 HIV 血清状态而异

Debroy, Paula; Barrett, Benjamin W; Erlandson, Kristine M; Budoff, Matthew; Brown, Todd T; Price, Jennifer C; Post, Wendy S; Stosor, Valentina; Skavarca, Carling; D'Souza, Gypsyamber; Lake, Jordan E

Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study

HIV感染者脂肪肝和肝纤维化的负担:一项美国多中心横断面研究

Gawrieh, Samer; Lake, Jordan E; Debroy, Paula; Sjoquist, Julia A; Robison, Montreca; Tann, Mark; Akisik, Fatih; Bhamidipalli, Surya S; Saha, Chandan K; Zachary, Kimon; Robbins, Gregory K; Gupta, Samir K; Chung, Raymond T; Chalasani, Naga; Corey, Kathleen E

Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus

非酒精性脂肪肝病与病毒载量受到抑制的人类免疫缺陷病毒感染者的健康相关生活质量受损无关

Gawrieh, Samer; Corey, Kathleen E; Lake, Jordan E; Samala, Niharika; Desai, Archita P; Debroy, Paula; Sjoquist, Julia A; Robison, Montreca; Tann, Mark; Akisik, Fatih; Bhamidipalli, Surya S; Saha, Chandan K; Zachary, Kimon; Robbins, Gregory K; Gupta, Samir K; Chung, Raymond T; Chalasani, Naga

Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatus

跨性别女性的心血管生物标志物指标比顺性别男性更差,且这种差异与激素使用情况和HIV血清状态无关。

Lake, Jordan E; Wang, Ruibin; Barrett, Benjamin W; Bowman, Emily; Hyatt, Ana N; Debroy, Paula; Candelario, Jury; Teplin, Linda; Bodnar, Kaitlin; McKay, Heather; Plankey, Michael; Brown, Todd T; Funderburg, Nicholas; Currier, Judith S

Antiretroviral Therapy Initiation Is Associated With Decreased Visceral and Subcutaneous Adipose Tissue Density in People Living With Human Immunodeficiency Virus

抗逆转录病毒疗法的开始与人类免疫缺陷病毒感染者内脏和皮下脂肪组织密度降低有关

Debroy, Paula; Lake, Jordan E; Moser, Carlee; Olefsky, Maxine; Erlandson, Kristine M; Scherzinger, Ann; Stein, James H; Currier, Judith S; Brown, Todd T; McComsey, Grace A

Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

改用整合酶抑制剂类抗逆转录病毒疗法后体重增加的风险因素

Lake, Jordan E; Wu, Kunling; Bares, Sara H; Debroy, Paula; Godfrey, Catherine; Koethe, John R; McComsey, Grace A; Palella, Frank J; Tassiopoulos, Katherine; Erlandson, Kristine M